The effect of Scalp-Cooling System on the prevention of alopecia after chemotherapy

Background: Breast cancer is the most common cancer among women worldwide. Post-operative chemotherapy plays an essential role in preventing recurrence and metastasis in patients with breast cancer. Since breast cancer chemotherapy has markedly improved in efficacy and has become more widely used, it is being administered to increasing numbers of patients. However, many patients may decline treatment because they are anxious about adverse effects, in particular hair loss. Cyclophosphamide, anthracycline, and taxane agents commonly cause hair loss, nausea, vomiting, and fever.

Source: European Journal of Cancer - September 30, 2020 Category: Cancer & Oncology Authors: H. Maseki, T. Kinoshita, A. Matsui, Y. Iwata, H. Harada, M. Sasahara, Y. Ichimura, Y. Murata, S. Urakami, S. Seki, T. Oishi, Y. Isobe Tags: POSTERS A: Supportive and Palliative Care Including End of Life Treatment Source Type: research